AFGVF: AI 评分 42/100 — AI 分析 (4月 2026)

Agfa-Gevaert NV is a global developer, producer, and distributor of analog and digital imaging systems, as well as IT solutions. The company operates through various segments, including Offset Solutions, Radiology Solutions, Healthcare IT, and Digital Print & Chemicals.

Key Facts: AI Score: 42/100 Sector: Industrials

公司概况

概要：

Agfa-Gevaert NV, founded in 1867, provides imaging solutions and IT services across diverse sectors, including printing, healthcare, and industrial applications. With a global reach and a focus on both analog and digital technologies, the company caters to specialized needs in hospitals, printing companies, and industrial manufacturers.

AFGVF是做什么的？

Agfa-Gevaert NV, established in 1867 and headquartered in Mortsel, Belgium, has evolved from a manufacturer of photographic materials to a provider of comprehensive imaging solutions and IT services. The company operates through four primary segments: Offset Solutions, Radiology Solutions, Healthcare IT, and Digital Print & Chemicals. The Offset Solutions segment offers integrated prepress and printing solutions, including computer-to-plate systems, pressroom supplies, and workflow software. The Radiology Solutions segment provides analog and digital imaging technologies for diagnostic purposes, including X-ray film, digital radiography equipment, and image processing software. The Healthcare IT segment delivers picture archiving and communication systems, hospital information systems, and integrated care solutions. The Digital Print & Chemicals segment focuses on inkjet printers, inks, and fluids for various industrial applications, as well as specialty films and materials. Agfa-Gevaert sells its products through its own sales organization and a network of agents and representatives worldwide.

AFGVF的投资论点是什么？

Agfa-Gevaert NV presents a complex investment case. The company's diverse portfolio across imaging and IT solutions offers exposure to multiple sectors, including healthcare and printing. However, its negative P/E ratio of -1.00 and a negative profit margin of -6.4% indicate profitability challenges. The company's beta of 0.58 suggests lower volatility compared to the market. Growth catalysts include expansion in the digital printing and healthcare IT segments. Investors should carefully consider the company's financial performance and competitive positioning before making investment decisions.

AFGVF在哪个行业运营？

Agfa-Gevaert NV operates in the industrial machinery sector, which is influenced by technological advancements and economic cycles. The company faces competition from established players and new entrants in each of its segments. The healthcare IT market is experiencing growth due to the increasing adoption of digital solutions in healthcare. The printing industry is evolving with the shift towards digital printing technologies. Agfa-Gevaert's ability to innovate and adapt to these trends will be crucial for its success.

Industrial - Machinery

Industrials

AFGVF有哪些增长机遇？

Expansion in Healthcare IT Solutions: Agfa-Gevaert can capitalize on the growing demand for healthcare IT solutions, including picture archiving and communication systems (PACS) and hospital information systems (HIS). The global healthcare IT market is projected to reach $440.2 billion by 2026, offering significant growth potential. By focusing on integrated care solutions and expanding its customer base in hospitals and imaging centers, Agfa-Gevaert can increase its market share and revenue.
Growth in Digital Printing and Industrial Inks: The digital printing market is expanding rapidly, driven by the increasing demand for customized and short-run printing. Agfa-Gevaert's Digital Print & Chemicals segment can benefit from this trend by offering inkjet printers, inks, and fluids for various industrial applications. The global digital printing market is expected to reach $40.8 billion by 2026. By developing innovative ink formulations and expanding its product portfolio, Agfa-Gevaert can strengthen its position in this market.
Development of Hydrogen Production Membranes: Agfa-Gevaert's expertise in membrane technology can be leveraged to develop membranes for hydrogen production. The demand for hydrogen as a clean energy source is increasing, driving the need for efficient and cost-effective hydrogen production methods. The global hydrogen generation market is projected to reach $201 billion by 2030. By investing in research and development and partnering with hydrogen technology companies, Agfa-Gevaert can tap into this emerging market.
Focus on Specialty Films and Materials: Agfa-Gevaert's Digital Print & Chemicals segment offers specialty films for various applications, including micrography, non-destructive testing, and security documents. These films cater to niche markets with specific requirements. By focusing on product innovation and expanding its customer base in these markets, Agfa-Gevaert can generate stable revenue streams and improve its profitability.
Geographic Expansion in Emerging Markets: Agfa-Gevaert can expand its presence in emerging markets, where the demand for imaging solutions and IT services is growing rapidly. By establishing partnerships with local distributors and tailoring its products to meet the specific needs of these markets, Agfa-Gevaert can increase its global reach and revenue. Emerging markets offer significant growth opportunities due to their increasing healthcare spending and industrial development.

Market capitalization of $0.09 billion reflects its current valuation in the market.
Negative P/E ratio of -1.00 indicates the company is currently not profitable.
Gross margin of 30.1% shows the percentage of revenue exceeding the cost of goods sold.
Beta of 0.58 suggests the stock is less volatile than the overall market.
The company operates in four segments: Offset Solutions, Radiology Solutions, Healthcare IT, and Digital Print & Chemicals.

AFGVF提供哪些产品和服务？

Develops and distributes analog and digital imaging systems.
Provides IT solutions for healthcare and industrial applications.
Offers integrated prepress and printing solutions for commercial, newspaper, and packaging printers.
Supplies X-ray film, hardcopy film, and digital radiography equipment for diagnostic imaging.
Delivers picture archiving and communication systems (PACS) for hospitals and imaging centers.
Produces inkjet printers, inks, and fluids for industrial inkjet applications.
Manufactures specialty films for micrography, non-destructive testing, and security documents.

AFGVF如何赚钱？

Develops and sells imaging hardware and software solutions.
Provides IT services and support to healthcare providers.
Generates revenue through sales of consumables, such as film and ink.
Offers maintenance and service contracts for its equipment.

Commercial, newspaper, and packaging printers.
Hospitals and imaging centers.
Sign and display printing companies.
Industrial manufacturers using inkjet printing.
Organizations requiring specialty films for security documents and print media.

Established brand reputation in the imaging industry.
Extensive product portfolio across multiple segments.
Global sales and distribution network.
Expertise in both analog and digital technologies.

什么因素可能推动AFGVF股价上涨？

Ongoing: Expansion in the healthcare IT market, driven by the increasing adoption of digital solutions in healthcare.
Ongoing: Growth in the digital printing market, fueled by the demand for customized and short-run printing.
Upcoming: Potential partnerships with hydrogen technology companies to develop membranes for hydrogen production.
Ongoing: Focus on product innovation and expansion in specialty films and materials.
Ongoing: Geographic expansion in emerging markets to increase global reach and revenue.

AFGVF的主要风险是什么？

Potential: Technological obsolescence in the imaging industry.
Potential: Economic downturns affecting demand for printing and industrial products.
Ongoing: Increased competition from larger and more diversified companies.
Potential: Regulatory changes impacting the healthcare and printing industries.
Ongoing: Negative profitability and P/E ratio indicating financial challenges.

AFGVF的核心优势是什么？

Diverse product portfolio across multiple segments.
Global sales and distribution network.
Expertise in both analog and digital technologies.
Established brand reputation in the imaging industry.

AFGVF的劣势是什么？

Negative profitability and P/E ratio.
Exposure to cyclical industries, such as printing.
Competition from larger and more diversified companies.
Dependence on specific markets and customers.

AFGVF有哪些机遇？

Expansion in healthcare IT solutions.
Growth in digital printing and industrial inks.
Development of hydrogen production membranes.
Geographic expansion in emerging markets.

AFGVF面临哪些威胁？

Technological obsolescence.
Economic downturns.
Increased competition.
Regulatory changes.

AFGVF的竞争对手是谁？

Akitae Co Ltd — Focuses on printing and coating solutions. — (ACTHF)
Brady Corp — Provides identification and specialty materials. — (BRYAF)
Canon Inc — Offers a wide range of imaging and optical products. — (CHHGF)
China Huadian Heavy Machinery Co Ltd — Specializes in heavy machinery manufacturing. — (CIHPF)
Hansol Paper Co Ltd — Produces paper and related products. — (HSPPF)

Key Metrics

MoonshotScore: 42/100

Company Profile

CEO: Pascal Juery
Headquarters: Mortsel, BE
Employees: 4,765
Founded: 2009

AI Insight

AI analysis pending for AFGVF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Agfa-Gevaert N.V. do?

Agfa-Gevaert NV develops, produces, and distributes a range of imaging systems and IT solutions. Its operations are divided into four segments: Offset Solutions, providing printing solutions; Radiology Solutions, offering diagnostic imaging technology; Healthcare IT, delivering healthcare information systems; and Digital Print & Chemicals, producing inkjet printers and specialty films. The company serves diverse sectors, including printing, healthcare, and industrial manufacturing, with a global sales and distribution network.

What do analysts say about AFGVF stock?

As of 2026-03-16, formal analyst ratings for AFGVF may be limited due to its OTC listing. Key valuation metrics include a market cap of $0.09 billion and a negative P/E ratio of -1.00. Growth considerations revolve around the company's ability to capitalize on opportunities in healthcare IT and digital printing. Investors should conduct their own due diligence and consider the risks associated with OTC stocks before investing.

What are the main risks for AFGVF?

Agfa-Gevaert faces several risks, including technological obsolescence in the imaging industry, economic downturns affecting demand for its products, and increased competition from larger companies. Its negative profitability and P/E ratio indicate financial challenges. As an OTC-listed stock, AFGVF is subject to risks related to limited financial disclosure, lower liquidity, and less regulatory oversight. These factors contribute to a higher risk profile for investors.